Identification
A:
The retention time of the insulin peak in the chromatogram of the Assay preparation corresponds to the retention time of the appropriate species in the chromatogram of the Identification preparation, as obtained in the Assay. [NOTEIt may be necessary to inject a mixture of Assay preparation and Identification preparation.]
B:
Proceed as directed for Identification test B under Insulin Human, except to use 1 mg of USP Insulin Reference Standard of the appropriate species to prepare the Standard digest solution, to use 1 mg of Insulin to prepare the Test digest solution, and to obtain a resolution, R, between digest fragments II and III of not less than 1.9: meets the requirements.
Related compounds
Solvent
Dissolve 28.4 g of anhydrous sodium sulfate in 1000 mL of water. Pipet 2.7 mL of phosphoric acid into this solution, adjust, if necessary, with ethanolamine to a pH of 2.3, and mix.
Solution A
Prepare a filtered and degassed mixture of Solvent and acetonitrile (82:18).
Solution B
Prepare a filtered and degassed mixture of Solvent and acetonitrile (50:50).
Mobile phase
Use variable mixtures of
Solution A and
Solution B as directed for
Chromatographic system. Make adjustments if necessary (see
System Suitability under
Chromatography 621).
System suitability solution
Proceed as directed in the Assay.
Standard solution A
Dissolve an accurately weighed quantity of
USP Insulin RS of the appropriate species in 0.01 N hydrochloric acid to obtain a solution having a known concentration of about 3.75 mg per mL.
Standard solution B
Pipet 1 mL of Standard solution A into a 10-mL volumetric flask, dilute with 0.01 N hydrochloric acid to volume, and mix.
Standard solution C
Pipet 1 mL of Standard solution B into a 10-mL volumetric flask, dilute with 0.01 N hydrochloric acid to volume, and mix.[NOTEThese three Standard solutions may be stored at room temperature for up to 12 hours and in a refrigerator for up to 48 hours.]
Test solution
Transfer about 7.5 mg of Insulin to a suitable capped vial, and add 2.0 mL of 0.01 N hydrochloric acid. Cap the vial, and shake gently to dissolve. Store this solution for not more than 2 hours at room temperature or for not more than 12 hours in a refrigerator.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 214-nm detector and a 4.6-mm × 25-cm column that contains packing L1. The column temperature is maintained at 40
, and the flow rate is about 1 mL per minute. The chromatograph is programmed as follows.
Time (minutes) |
Solution A
% |
Solution B
% |
Elution |
0 |
81 |
19 |
equilibration |
060 |
81 |
19 |
isocratic |
6085 |
81®36 |
19®64 |
linear gradient |
8591 |
36 |
64 |
isocratic |
9192 |
36®81 |
64®19 |
linear gradient |
Adjust the
Mobile phase composition and the duration of the isocratic elution to obtain a retention time of about 31 minutes for insulin, with the A-21 desamido insulin eluting just prior to the start of the gradient elution phase. Chromatograph
Standard solutions A, B, and
C, record the chromatograms, and measure the peak responses as directed for
Procedure: calculate the factor
X1 by the formula:
10(rB / rA),
in which
rB and
rA are the areas of the peak responses obtained for
Standard solution B and
Standard solution A, respectively. The value of
X1is between 0.91 and 1.09. Calculate the factor
X2 by the formula:
100(rC / rA),
in which
rC and
rA are the areas of the peak responses obtained for
Standard solution C and
Standard solution A, respectively. The value of
X2 is between 0.7 and 1.3. Chromatograph the
System suitability solution, and record the peak responses as directed for
Procedure: the resolution,
R, between insulin and A-21 desamido insulin is not less than 2.0; and the tailing factor for the insulin peak is not more than 1.8.
Procedure
Inject a volume (about 20 µL) of the
Test solution into the chromatograph, record the chromatogram, and measure the areas of the responses for the main insulin peak, the A-21 desamido insulin peak, and the peaks from any other impurities. Calculate the percentage of insulin, %
I, in the portion of Insulin taken by the formula:
100(rI / rs),
in which
rI is the peak response for insulin, and
rs is the sum of the responses for all of the peaks. Calculate the percentage of A-21 desamido insulin, %
D, in the portion of Insulin taken by the formula:
100(rD / rs),
in which
rD is the peak response for A-21 desamido insulin, and
rs is the sum of the responses for all of the peaks. Calculate the percentage of other insulin related compounds in the portion of Insulin taken by the formula:
100
(%
I + %
D).
Not more than 10.0% of A-21 desamido insulin is found, and not more than 5.0% of other insulin related compounds is found. For Insulin derived from a single species, measure the responses of any peaks corresponding to beef or pork insulin, and calculate their concentration as a percentage of
rs : the amount of cross-contamination is not more than 1.0%.
Limit of high molecular weight proteins
Arginine solution
Prepare a solution of L-arginine in water containing 1 mg per mL.
Mobile phase
Prepare a filtered and degassed mixture of
Arginine solution, acetonitrile, and glacial acetic acid (65:20:15). Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Resolution solution
Dissolve 4 mg of Insulin containing more than 0.4% high molecular weight proteins in 1 mL of 0.01 N hydrochloric acid. Store this solution in a refrigerator, and use within 7 days. [NOTEInsulin containing the indicated percentage of high molecular weight proteins may be prepared by allowing Insulin to stand at room temperature for about 5 days.]
Test solution
Transfer about 4 mg of Insulin to a small vial, add 1 mL of 0.01 N hydrochloric acid, and mix to dissolve. Store in a refrigerator, and use within 7 days.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 276-nm detector and a 7.8-mm × 30-cm column that contains packing L20. The flow rate is about 0.5 mL per minute. Chromatograph the
Resolution solution, and record the peak responses as directed for
Procedure: the retention times are between 13 and 17 minutes for the polymeric insulin complexes, about 17.5 minutes for the covalent insulin dimer, and between 18 and 22 minutes for the insulin monomer, with salts eluting after the insulin monomer; and the ratio of the height of the covalent insulin dimer peak to the height of the valley between the covalent insulin dimer peak and the insulin monomer peak is not less than 2.0.
Procedure
Inject a volume (about 100 µL) of the
Test solution into the chromatograph, record the chromatogram, and measure the areas of the peak responses, disregarding any peaks having retention times greater than that of the insulin monomer. Calculate the percentage of high molecular weight proteins in the portion of Insulin taken by the formula:
100SrH / (SrH + rM),
in which
SrH is the sum of the responses for all peaks having retention times less than that of the insulin monomer, and
rM is the peak response of the insulin monomer: not more than 1.0% is found.
Assay
Mobile phase
Dissolve 28.4 g of anhydrous sodium sulfate in 1000 mL of water, pipet 2.7 mL of phosphoric acid into the solution, and adjust with ethanolamine to a pH of 2.3 if necessary. Prepare a filtered and degassed mixture of this solution and acetonitrile (74:26). The acetonitrile is warmed to a temperature equal to or higher than 20
to avoid precipitation. Make adjustments if necessary (see
System Suitability under
Chromatography 621).
System suitability solution
Dissolve about 1.5 mg of Insulin in 1.0 mL of 0.01 N hydrochloric acid. Allow to stand at room temperature for not less than 3 days to obtain a solution containing not less than 5% of A-21 desamido insulin.
NOTEThe following Identification preparation, Standard preparation, and Assay preparation may be stored at room temperature for up to 12 hours or in a refrigerator for up to 48 hours.
Standard preparation
Dissolve an accurately weighed quantity of
USP Insulin RS of the appropriate species in 0.01 N hydrochloric acid to obtain a solution having a known concentration of about 1.5 mg per mL.
Assay preparation
Transfer about 15 mg of Insulin, accurately weighed, to a 10-mL volumetric flask, and dissolve in and dilute with 0.01 N hydrochloric acid to obtain a solution having a concentration of about 1.5 mg per mL.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 214-nm detector and a 4.6-mm × 15-cm column that contains packing L1. The column temperature is maintained at 40
, and the flow rate is about 1 mL per minute. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation for replicate injections is not more than 1.6%. Chromatograph the
System suitability solution, and record the peak responses as directed for
Procedure: the resolution,
R, between insulin and A-21 desamido insulin is not less than 2.0; and the tailing factor for the insulin peak is not more than 1.8.
Procedure
Separately inject equal volumes (about 20 µL) of the
Assay preparation, the
Identification preparation, and the
Standard preparation into the chromatograph, record the chromatograms, and measure the peak responses for insulin and A-21 desamido insulin, using the chromatogram of the
Identification preparation to identify the insulin peaks. For Insulin derived from a single species, calculate the potency on the undried basis, in USP Insulin Units per mg, of the Insulin in the
Assay preparation by the formula:
(CS / CU)(SrU /SrS),
in which
CS is the concentration, in USP Insulin Units per mL, of USP Insulin RS in the
Standard preparation; CU is the concentration, in mg per mL, of Insulin in the
Assay preparation; and
SrU and
SrS are the sums of the areas of the insulin and A-21 desamido insulin peaks obtained from the chromatograms of the
Assay preparation and the
Standard preparation, respectively. From the value obtained in the test for
Loss on drying, calculate the potency on the dried basis. For Insulin derived from a mixture of beef and pork, calculate the total potency as the sum of the potencies of the beef- and pork-derived insulins, determined separately.